PLYMOUTH
MEETING, Pa., April 16,
2024 /PRNewswire/ -- Harmony Biosciences Holdings,
Inc. (Nasdaq: HRMY) today announced that it will report first
quarter 2024 financial results on Tuesday,
April 30, 2024, before the open of the U.S. financial
markets. Harmony will host a conference call and live webcast on
April 30, 2024, at 8:30 a.m. ET to discuss the results.
To participate in the call, please dial (800) 579-2543
(domestic) or +1 (785) 424-1789 (international), and reference
passcode HRMYQ124. It is recommended that you dial in at least 10
minutes prior to the call.
The live and replay webcast of the call will be available on the
investor page of our website at
https://ir.harmonybiosciences.com/.
About Harmony Biosciences
At Harmony Biosciences, we specialize in developing and delivering
treatments for rare neurological diseases that others often
overlook. We believe that where empathy and innovation meet, a
better life can begin for people living with neurological diseases.
Established by Paragon Biosciences, LLC, in 2017 and headquartered
in Plymouth Meeting, PA, our team
of experts from a wide variety of disciplines and experiences is
driven by our shared conviction that innovative science translates
into therapeutic possibilities for our patients, who are at the
heart of everything we do. For more information, please visit
www.harmonybiosciences.com.
Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com
Harmony Biosciences Media Contact:
Cate McCanless
202-641-6086
cmccanless@harmonybiosciences.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-report-first-quarter-2024-financial-results-on-april-30-2024-302117222.html
SOURCE Harmony Biosciences